{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:33:14Z","timestamp":1740126794895,"version":"3.37.3"},"reference-count":41,"publisher":"Georg Thieme Verlag KG","issue":"01","funder":[{"DOI":"10.13039\/100013223","name":"PTC Therapeutics","doi-asserted-by":"crossref","award":["Investigator initiated grant"],"award-info":[{"award-number":["Investigator initiated grant"]}],"id":[{"id":"10.13039\/100013223","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropediatrics"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Introduction\u2003Children with Duchenne muscular dystrophy (DMD) are at risk of experiencing fatigue that negatively impacts their health-related quality of life (HRQoL). This study aimed to assess the association between fatigue and HRQoL, by examining fatigue trajectories over 48 weeks, and assessing factors associated with these fatigue trajectories.<\/jats:p><jats:p>\n          Methods\u2003The study sample consisted of 173 DMD subjects enrolled in a 48-week-long phase 2 clinical trial (NCT00592553) for a novel therapeutic who were between the ages of 5 and 16 years.<\/jats:p><jats:p>\n          Results\u2003The results of regression modeling show baseline fatigue and baseline HRQoL (R\n          2\u2009=\u20090. 54 for child self-report and 0.51 for parent proxy report) and change in fatigue and HRQoL over 48 weeks (R\n          2\u2009=\u20090.47 for child self-report and 0.36 for parent proxy report) were significantly associated with one another. Three unique fatigue trajectories using Latent Class Growth Models were identified for child and parent proxy reported fatigue. The risk of being in the high fatigue group as compared to the low fatigue group increased by 24% with each year increase in age and also with decreasing walking distance, as reported by children and parent proxy, respectively.<\/jats:p><jats:p>\n          Conclusion\u2003This study identified fatigue trajectories and risk factors associated with greater fatigue, helping clinicians and researchers identify the profile of fatigue in DMD children.<\/jats:p>","DOI":"10.1055\/a-2101-7860","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T23:06:20Z","timestamp":1685142380000},"page":"042-048","source":"Crossref","is-referenced-by-count":1,"title":["Duchenne Muscular Dystrophy Fatigue Trajectories"],"prefix":"10.1055","volume":"55","author":[{"given":"Yi Sally","family":"Wei","sequence":"additional","affiliation":[{"name":"Children's Hospital London Health Sciences Centre, London, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Hnaini","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basmah","family":"ElAloul","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenio","family":"Zapata","sequence":"additional","affiliation":[{"name":"Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Campbell","sequence":"additional","affiliation":[{"name":"Children's Hospital London Health Sciences Centre, London, Canada"},{"name":"Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada"},{"name":"Department of Paediatrics, Clinical Neurological Sciences and Epidemiology, Western University, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"K Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/gte.1998.2.55","article-title":"Neonatal screening for Duchenne muscular dystrophy: a novel semiquantitative application of the bioluminescence test for creatine kinase in a pilot national program in Cyprus","volume":"2","author":"A Drousiotou","year":"1998","journal-title":"Genet Test"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"F91","DOI":"10.1136\/fn.86.2.F91","article-title":"Newborn screening for Duchenne muscular dystrophy: a psychosocial study","volume":"86","author":"E P Parsons","year":"2002","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases: a world survey","volume":"1","author":"A E Emery","year":"1991","journal-title":"Neuromuscul Disord"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"K Bushby","year":"2010","journal-title":"Lancet Neurol"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0960-8966(02)00140-2","article-title":"Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation","volume":"12","author":"M Eagle","year":"2002","journal-title":"Neuromuscul Disord"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1049909109358420","article-title":"Assessment and management of fatigue in neuromuscular disease","volume":"27","author":"J-S Lou","year":"2010","journal-title":"Am J Hosp Palliat Care"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.smrv.2005.05.004","article-title":"Distinguishing sleepiness and fatigue: focus on definition and measurement","volume":"10","author":"J Shen","year":"2006","journal-title":"Sleep Med Rev"},{"issue":"02","key":"ref9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1542\/peds.95.2.179","article-title":"Case control study of chronic fatigue in pediatric patients","volume":"95","author":"B D Carter","year":"1995","journal-title":"Pediatrics"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.pmr.2008.12.004","article-title":"Fatigue in children with neurologic impairments","volume":"20","author":"M Nutini","year":"2009","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"07","key":"ref11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1177\/0883073815627879","article-title":"Factors associated with health-related quality of life in children with Duchenne muscular dystrophy","volume":"31","author":"Y Wei","year":"2016","journal-title":"J Child Neurol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/dmcn.14248","article-title":"Fatigue in Young People with Duchenne Muscular Dystrophy","volume":"62","author":"B El-Aloul","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"03","key":"ref13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nmd.2016.01.003","article-title":"Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study","volume":"26","author":"S Messina","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.apmr.2015.02.012","article-title":"Prevalence of fatigue, pain, and affective disorders in adults with Duchenne muscular dystrophy and their associations with quality of life","volume":"96","author":"R F Pangalila","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"e1015","DOI":"10.1542\/peds.2014-2440","article-title":"Fatigue in child chronic health conditions: a systematic review of assessment instruments","volume":"135","author":"A Crichton","year":"2015","journal-title":"Pediatrics"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/dmcn.12964","article-title":"Understanding fatigue in paediatric multiple sclerosis: a systematic review of clinical and psychosocial factors","volume":"58","author":"S Carroll","year":"2016","journal-title":"Dev Med Child Neurol"},{"issue":"04","key":"ref17","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ejpn.2009.09.004","article-title":"Fatigue and depression in children with multiple sclerosis and monophasic variants","volume":"14","author":"I A Ketelslegers","year":"2010","journal-title":"Eur J Paediatr Neurol"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1177\/0883073812450750","article-title":"Fatigue and depression in children with demyelinating disorders","volume":"28","author":"J B Parrish","year":"2013","journal-title":"J Child Neurol"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/dmcn.12736","article-title":"Fatigue is a major issue for children and adolescents with physical disabilities","volume":"57","author":"C Maher","year":"2015","journal-title":"Dev Med Child Neurol"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/mus.24332","article-title":"Ataluren treatment of patients with nonsense mutation dystrophinopathy","volume":"50","author":"K Bushby","year":"2014","journal-title":"Muscle Nerve"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005650-199902000-00003","article-title":"The PedsQL: measurement model for the pediatric quality of life inventory","volume":"37","author":"J W Varni","year":"1999","journal-title":"Med Care"},{"issue":"07","key":"ref22","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/cncr.10428","article-title":"The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module","volume":"94","author":"J W Varni","year":"2002","journal-title":"Cancer"},{"issue":"12","key":"ref23","first-page":"2494","article-title":"The PedsQL Multidimensional Fatigue Scale in pediatric rheumatology: reliability and validity","volume":"31","author":"J W Varni","year":"2004","journal-title":"J Rheumatol"},{"issue":"08","key":"ref24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"J W Varni","year":"2001","journal-title":"Med Care"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/CND.0b013e3181c5053b","article-title":"The PedsQL in pediatric patients with Duchenne muscular dystrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Neuromuscular Module and Generic Core Scales","volume":"11","author":"S E Davis","year":"2010","journal-title":"J Clin Neuromuscul Dis"},{"issue":"08","key":"ref26","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/pbc.24491","article-title":"PedsQL\u2122 sickle cell disease module: feasibility, reliability, and validity","volume":"60","author":"J A Panepinto","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"08","key":"ref27","first-page":"783","article-title":"The six-minute walk test","volume":"48","author":"P L Enright","year":"2003","journal-title":"Respir Care"},{"issue":"04","key":"ref28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.21544","article-title":"The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy","volume":"41","author":"C M McDonald","year":"2010","journal-title":"Muscle Nerve"},{"issue":"06","key":"ref29","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/mus.21808","article-title":"The 6-minute walk test in Duchenne\/Becker muscular dystrophy: longitudinal observations","volume":"42","author":"C M McDonald","year":"2010","journal-title":"Muscle Nerve"},{"issue":"03","key":"ref30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/mus.23905","article-title":"The 6-minute walk test and other clinical endpoints in Duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study","volume":"48","author":"C M McDonald","year":"2013","journal-title":"Muscle Nerve"},{"issue":"03","key":"ref31","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0049124101029003005","article-title":"A SAS procedure based on mixture models for estimating developmental trajectories","volume":"29","author":"B L Jones","year":"2001","journal-title":"Sociological Methods & Research"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000360229","article-title":"Group-Based Trajectory Modeling: An Overview","volume":"65","author":"D S Nagin","year":"2014","journal-title":"Ann Nutr Metab"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.20982\/tqmp.05.1.p011","article-title":"Latent class growth modelling: A Tutorial","volume":"05","author":"A Andruff","year":"2009","journal-title":"Tutor Quant Methods Psychol"},{"issue":"09","key":"ref34","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1007\/s00520-016-3234-y","article-title":"The impact of dexamethasone and prednisone on sleep in children with acute lymphoblastic leukemia","volume":"24","author":"L C Daniel","year":"2016","journal-title":"Support Care Cancer"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3233\/JND-180346","article-title":"Management of adrenal insufficiency risk after long-term systemic glucocorticoid therapy in Duchenne muscular dystrophy: clinical practice recommendations","volume":"6","author":"S A Bowden","year":"2019","journal-title":"J Neuromuscul Dis"},{"issue":"02","key":"ref36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/dmcn.14248","article-title":"Fatigue in young people with Duchenne muscular dystrophy","volume":"62","author":"B El-Aloul","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"07","key":"ref37","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s11136-014-0642-7","article-title":"The level of agreement between child self-reports and parent proxy-reports of health-related quality of life in boys with Duchenne muscular dystrophy","volume":"23","author":"Y Lim","year":"2014","journal-title":"Qual Life Res"},{"issue":"06","key":"ref38","doi-asserted-by":"crossref","first-page":"e1559","DOI":"10.1542\/peds.2012-0858","article-title":"Health-related quality of life in children and adolescents with Duchenne muscular dystrophy","volume":"130","author":"K Uzark","year":"2012","journal-title":"Pediatrics"},{"issue":"10","key":"ref39","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1177\/0883073809357624","article-title":"Health-related quality of life in boys with Duchenne muscular dystrophy: agreement between parents and their sons","volume":"25","author":"P Bray","year":"2010","journal-title":"J Child Neurol"},{"issue":"09","key":"ref40","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.nmd.2012.06.256","article-title":"S.P.31 what was the age and cause of death in patients with Duchenne muscular dystrophy in Sweden during 2000\u20132010","volume":"22","author":"A Stromberg","year":"2012","journal-title":"Neuromuscul Disord"},{"issue":"08","key":"ref41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/ph14080785","article-title":"Ataluren: promising therapeutic premature termination codon readthrough frontrunner","volume":"14","author":"S Michorowska","year":"2021","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["Neuropediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2101-7860.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T14:28:28Z","timestamp":1730816908000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2101-7860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":41,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,1,12]]},"published-print":{"date-parts":[[2024,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2101-7860","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0174-304X","1439-1899"],"issn-type":[{"type":"print","value":"0174-304X"},{"type":"electronic","value":"1439-1899"}],"subject":[],"published-other":{"date-parts":[[2023,5,26]]},"published":{"date-parts":[[2023,5,26]]}}}